Effective dosing and dose equivalency of second-generation antipsychotic medications.

Peter F Buckley

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Dosing patterns with second-generation antipsychotic medications (SGAs) are dynamic, with some SGAs surpassing current recommendations while others are declining in dose since their initial regulatory guidelines. Pertinent recent studies and available pharmacoepidemiologic reports, information, and expert consenses are reviewed herein to illuminate current thinking on the topic of dosing with SGAs. There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs.

Original languageEnglish (US)
Pages (from-to)24-31
Number of pages8
JournalCNS Spectrums
Volume9
Issue number9 Suppl 9
StatePublished - Jan 1 2004

Fingerprint

Antipsychotic Agents
Guidelines

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Effective dosing and dose equivalency of second-generation antipsychotic medications. / Buckley, Peter F.

In: CNS Spectrums, Vol. 9, No. 9 Suppl 9, 01.01.2004, p. 24-31.

Research output: Contribution to journalReview article

Buckley, Peter F. / Effective dosing and dose equivalency of second-generation antipsychotic medications. In: CNS Spectrums. 2004 ; Vol. 9, No. 9 Suppl 9. pp. 24-31.
@article{c0cd2b1896f34025a4dff6f199fb110b,
title = "Effective dosing and dose equivalency of second-generation antipsychotic medications.",
abstract = "Dosing patterns with second-generation antipsychotic medications (SGAs) are dynamic, with some SGAs surpassing current recommendations while others are declining in dose since their initial regulatory guidelines. Pertinent recent studies and available pharmacoepidemiologic reports, information, and expert consenses are reviewed herein to illuminate current thinking on the topic of dosing with SGAs. There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs.",
author = "Buckley, {Peter F}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
volume = "9",
pages = "24--31",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "9 Suppl 9",

}

TY - JOUR

T1 - Effective dosing and dose equivalency of second-generation antipsychotic medications.

AU - Buckley, Peter F

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Dosing patterns with second-generation antipsychotic medications (SGAs) are dynamic, with some SGAs surpassing current recommendations while others are declining in dose since their initial regulatory guidelines. Pertinent recent studies and available pharmacoepidemiologic reports, information, and expert consenses are reviewed herein to illuminate current thinking on the topic of dosing with SGAs. There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs.

AB - Dosing patterns with second-generation antipsychotic medications (SGAs) are dynamic, with some SGAs surpassing current recommendations while others are declining in dose since their initial regulatory guidelines. Pertinent recent studies and available pharmacoepidemiologic reports, information, and expert consenses are reviewed herein to illuminate current thinking on the topic of dosing with SGAs. There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs.

UR - http://www.scopus.com/inward/record.url?scp=16544365514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544365514&partnerID=8YFLogxK

M3 - Review article

C2 - 15361809

AN - SCOPUS:16544365514

VL - 9

SP - 24

EP - 31

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 9 Suppl 9

ER -